Bosch finalizes acquisition of Eisai Machinery
- Details
- Published on Tuesday, 17 April 2012 08:18
- Written by Staff Reporter
JAPAN – Bosch Packaging Technology has finalized its acquisition of Eisai Machinery - the machinery business companies of leading Japanese pharmaceutical company Eisai Co Ltd.
The transaction has been approved by the antitrust authorities without further restrictions. The entire share and equity interest of Eisai Machinery – involved in the manufacture, sales and export of inspection equipment as well as pharmaceutical machinery and packaging materials - is transferred to the Bosch Group.
With sales of around EUR 76 million (¥8.6 billion) of 2010, Eisai Machinery consists of four subsidiaries with 120 associates: Eisai Machinery Co., Ltd. (Japan), Eisai Machinery U.S.A. Inc. (North America), Eisai Machinery GmbH (Germany) and Eisai Machinery Shanghai Co., Ltd (China). All locations will be integrated into the worldwide Bosch network.
Inspection technology from Eisai Machinery is used for liquid and solid pharmaceuticals, such as ampoules, syringes, vials and tablets. Solutions offered range from basic inspection solutions to fully automated high-performance systems. Eisai Machinery has installed more than 1,000 inspection machines worldwide. “Adding these competencies to our portfolio further enhances our position as full-range provider to the pharmaceutical industry”, said Friedbert Klefenz, President of Bosch Packaging Technology. “We will quickly merge our expertise and expand our presence globally.”
Joachim Baczewski, President of Bosch Packaging Technology in Japan added, “The combined product portfolio, know-how and experience of Bosch Packaging Technology and Eisai Machinery will form a solid basis for the provision of a comprehensive range of innovative solutions to our customers.“
“We contribute to the safety of pharmaceutical products used by patients worldwide,” said Kenji Hanawa, President of Eisai Machinery Co Ltd. “With Bosch we have found a partner who shares our vision.”
See related story:
